This live facilitated two-part course provides clinicians the knowledge and confidence to prescribe gender affirming hormone therapy (GAHT) based on the needs of their patient population utilising an informed consent model.
Clinicians will also be supported to create a gender affirming practice and establish a business model for ongoing financial sustainability.
7.5 CPD hours
No upcoming sessions that suit you? Express your interest to be notified if a course is planned in your area.
On completion of this course, participants will be able to train co-workers on antenatal syphilis testing, and will be able to:
Pre-course survey
(prerequisite/highly recommended, 1.5 additional CPD hours)
online learning module (prerequisite/highly recommended, 1.5 additional CPD hours)
Two 2-hour live online workshops (4 CPD hours)
Post-course survey and competency assessment (0.5 CPD hours)
This is an RACGP-approved CPD activity under the RACGP CPD Program (2 Educational Activity hours, 2.5 Reviewing Performance hours). Additional 3 CPD hours available by completing the prerequisite online learning modules.
This activity has been accredited in the 2026 – 2028 ACRRM CPD Program.
All participants who attend the course in full will be awarded a Statement of Attendance. Please note you will receive separate statements of attendance for the online learning modules and facilitated training.
Course participants seeking to receive a certification acknowledging they have met the standards outlined by ASHM, ACON and AusPATH to be a competent prescriber of gender affirming hormone therapy must fulfil the following criteria:
Clinicians currently or seeking to prescribe gender affirming hormone therapy.
Guidelines for health practitioners, including general practitioners, nurses and midwives, managing people living with HIV in Australasia. It provides information on basic principles of preventing, diagnosing, and managing HIV-associated diseases.
The HIV Monitoring Tool is a 2-page resource designed to provide HIV s100 prescribers a structured framework for conducting thorough patient reviews following an HIV diagnosis.
This practical two-page resource outlines key considerations for the comprehensive monitoring of cisgender women living with HIV. The resource guides clinicians through history taking, examination, clinical evaluation, and initiation of antiretroviral therapy.
This two-hour online learning module will increase primary care providers’ knowledge and confidence in providing evidence-based and patient-centered contraceptive consultations. The course outlines the efficacy, advantages, and disadvantages of contraceptive options to promote shared decision-making and reduce the incidence of unintended pregnancy amongst their patient population.
Become a HIV s100 prescriber to manage and treat HIV in primary care settings.
Become a hepatitis B s100 prescriber to manage and treat chronic hepatitis B in primary care settings.
Are you passionate about educating other healthcare professionals on your area of expertise?
Express your interest in speaking at future ASHM courses
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM